NCT05478941

Brief Summary

The purposes of the current research project are as follows:

  1. 1.investigate if the PMRT associated with a personalized-relaxing scenario in VR can facilitate the recalling of the relaxing image in the real world than the standard procedure (consisting of PMRT associated with the in-imagination exposure to a comfortable subjective context). The investigators assume that VR would be more efficient than in-imagination since it would make easy the visualization process favor people cope with more realistic sensory experiences than in-imagination exposure. Accordingly, the VR exposure would elicit the strongest association between the relaxation procedure (neutral stimulus, NS) and the relaxing context in VR (conditioning stimulus, CS);
  2. 2.whether exposure to a personalized VREs has a more significant impact on anxiety, depression, stress, sense of presence, and quality of psychological well-being; these constructs are investigated by comparing the participants' performance on self-report questionnaires (described in the next section), before the start of the training (T0; baseline), at the end of all the four relaxing sessions, one week after the end of relaxation sessions (T1; day 7), and during follow up (T2; day 14);
  3. 3.if the relaxing sessions administered via Zoom are more proper for managing anxiety and stress than a procedure learned via an audio registration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 16, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 28, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 24, 2023

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

1.5 years

First QC Date

July 16, 2022

Last Update Submit

November 28, 2023

Conditions

Outcome Measures

Primary Outcomes (12)

  • Number of participants with VR-related side effects as assessed by the Virtual Reality Sickness Questionnaire and the investigators' observations.

    Participants in the two experimental arms is asked to refer if the VR head mounted display was painful, too heavy, or uncomfortable. More in detail, participants is asked if they have experienced negative side effect during the Virtual Reality (VR) exposure based on the Virtual Reality Sickness Questionnaire (VRSQ), administered at the end of the VR exposure. This questionnaire is based on a dichotomous answer (Yes/No). During the VR experience, the investigator observe participant reactions and record behaviors and signs suggesting an unpleasant experience.

    T1 (day 7)

  • Change is being assessed between and within subjects in depression scores

    Differences between groups and change from baseline to T1 and T2 phases in depression scores are assessed based on the "Depressive Anxiety Stress Scale-21-Depression subscale". Items are answered according on a 4-point Likert scale (0-3). Scores ranging from 0 to 42 (the scores will need to be multiplied by 2 to calculate the final score). Higher scores indicated more depression severity.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in trait-anxiety scores

    Differences between groups and change from baseline to T1 and T2 phases in trait-anxiety scores are assessed based on the State-Trait Anxiety Inventory-Y2 (Trait Anxiety). The measure is a self-report questionnaire investigating the trait anxiety based on a 4-point Likert scale (1-4). Scores ranging from 20 to 80. Higher scores indicated higher trait-anxiety severity.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in state-anxiety scores

    Differences between groups and change from baseline to T1 and T2 phases in state-anxiety scores are assessed based on the State-Trait Anxiety Inventory-Y1 (State anxiety) before and after each sessions. The STAI-Y1 is a self-report questionnaire investigating the state anxiety based on a 4-point Likert scale (1-4). Scores ranging from 20 to 80. Higher scores indicated more state-anxiety severity.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in autonomic arousal, skeletal muscle effects, situational anxiety, subjective experience of anxious affect.

    Differences between groups and change from baseline to T1 and T2 phases in anxiety scores are assessed by the "Depressive Anxiety Stress Scale-21-Anxiety Subcale" based on a 4-point Likert scale (0-3). Scores ranging from 0 to 42 (the scores will need to be multiplied by 2 to calculate the final score). Higher scores indicated more anxiety severity.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in bodily anxiety sensations

    Differences between groups and change from baseline to T1 and T2 phases in bodily anxiety sensations scores are assessed based on the Self Assessment Manikin (SAM). The SAM is a non-verbal imagery-based assessment technique used to assess bodily anxiety sensations that directly measures the pleasure, arousal, and dominance associated with a person's affective reaction to a wide variety of stimuli. Each sensations is assessed on 5 different images distributed in order of size. Participants can tick either of the five pictures or any of the four spaces in between, making it essentially a 9-point Likert-scale. The SAM varies from a minimum score of 3 to a maximum score of 27. The huge non-verbal imagery are related with higher bodily anxiety sensations.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in levels of chronic non-specific arousal (stress)

    Differences between groups and change from baseline to T1 and T2 phases in levels of chronic nonspecific arousal (stress) scores are assessed by the "Depressive Anxiety Stress Scale-21-Stress subscale" based on a 4-point Likert scale (0-3). Scores ranging from 0 to 42 (the score will need to be multiplied by 2 to calculate the final score). Higher scores indicated higher level of stress.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in relaxation levels

    Differences between groups and change from baseline to T1 and T2 phases in relaxation levels are assessed based on the Visual Analog Scale administered before and after each sessions. This measure assess relaxation levels before and after each virtual reality experience. Participants had to express how relaxed they felt (0 =not at all relaxed; 10=completely relaxed; 0 =absent; 10=complete). Higher scores indicated higher relaxation levels.

    T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in quality of life scores

    Change from baseline to T1 and T2 phases in quality of life scores on the Psychological General Well-Being Index are assessed at three different assessment times. The measure consists of 22 self-administered items, rated on a 6-point scale (0-5), which assess the psychological and general well-being. Scores ranging from 0 to 110. Higher scores indicated a better well-being state.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in coping strategies scores

    Change from baseline to T1 and T2 phases in coping strategies are assessed at three different assessment times. The Coping Orientation to the Problems Experienced-New Italian Version is a self-report questionnaire developed to assess the different coping strategies people use in response to stress; it is based on 60 items rated on a 4-point scale (1-4). Total scores ranging from 60 to 240. Higher scores indicate that a certain cope strategies is frequently used by the person.

    T0 (baseline), T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in sense of presence scores related to the Virtual Reality and Guided Imagery experiences

    Differences between groups and change from T1 and T2 phases in sense of presence related to the VR or Guided Imagery experience are assessed at two different assessment times based on a Visual Analogue Scale and the ITC-Sense of Presence Inventory (ITC-SOPI). The ITC-SOPI is a self-report questionnaire assessing the sense of presence. Items are rated on a 5-point Likert scale (1-5). Scores ranging from 36 to 180. To obtain the scores for each of the scales, the average of the items have to be calculated. Higher scores indicated higher sense of presence.

    T1 (day 7), T2 (day 14)

  • Change is being assessed between and within subjects in hearth frequency

    Differences between groups and change from baseline to T1 and T2 phases in hearth frequency are assessed based on the Xiaomi Mi Band 2 tool. It is used in three different assessment times (T0, T1, T2). During T1 and T2 hearth frequency is measured before, during, and after the in-presence relaxation session.

    T0 (baseline), T1 (day 7), T2 (day 14)

Study Arms (3)

Progressive Muscle Relaxation training via Zoom and Guided Imagery exposure

ACTIVE COMPARATOR

A standardized protocol regarding the information on the training background is shared with participants. Then, they are invited to participate in four individual PMRT sessions (two sessions per week) deployed via Zoom. The fifth session after a week (T1; day 7) is administered in-presence at the Virtual Reality laboratory (A10-A11)- University of Padova; here an in-imagination relaxing scenario is built up with the support of the Psychotherapist; then, participants are exposed to an in-vivo PMRT relaxing session conducted by the Psychotherapist, with the request to think about the in-imagination relaxing scenario, created before, during the progressive relaxation procedure. After two weeks (T2; day 14), at the follow-up phase, the therapist asks to recover the in-imagination relaxing scenario and relax, giving participants the time allowed for the last guided relaxing session.

Behavioral: Progressive Muscular Relaxation via Zoom, and Exposure to a Guided Imagery Exposure.

Progressive Muscle Relaxation training via Zoom and personalized VR exposure

EXPERIMENTAL

PMRT sessions and expected time length are the same as for the first group. Differences regard the fifth session after a week (T1; day 7), where the relaxing scenario is built with the psychotherapist's support based on the VR's tools. Indeed, during the in-presence session, participants are exposed to a merged personalized relaxing VR scenario and PMRT session administered by the Oculus Quest 2 tool. During the follow-up (T2; day 14), it is asked to recover the image and relax, making available the same time allowed for the last guided session.

Combination Product: Progressive Muscular Relaxation via Zoom, and Exposure to a Virtual Reality scenarios deployed by an Head mounted tool (Oculus Quest 2).

Progressive Muscle Relaxation training based on audio-recording and personalized VR exposure

EXPERIMENTAL

A standardized protocol of information and the four PMRT sessions is administered individually based on an audio-track through the Moodle e-learning platform of the University of Padova. During the fifth session after a week (T1; day 7), users are asked to participate in an in-presence session in which they are exposed to a merged personalized, relaxing VR scenario and a PMRT session administered based on the Oculus Quest 2 tool. The last follow-up session (T2; day 14) has the same features as the other groups.

Combination Product: Progressive Muscular Relaxation via Audio-track, and Exposure to a Virtual Reality scenarios deployed by an Head mounted tool (Oculus Quest 2).

Interventions

* Four individual PMRT sessions via Zoom. * In vivo PMRT relaxing session and Virtual Reality exposure (T1; day 7). * Follow-up phase (T2; day 14), after two weeks. Recovering the virtual reality scenario based on an in-imagination session, and the PMRT session.

Progressive Muscle Relaxation training via Zoom and personalized VR exposure

* Four individual PMRT sessions via Audio-track. * In vivo PMRT relaxing session and Virtual Reality exposure (T1; day 7). * Follow-up phase (T2; day 14), after two weeks. Recovering the virtual reality scenario based on an in-imagination session, and the PMRT session.

Progressive Muscle Relaxation training based on audio-recording and personalized VR exposure

* Four individual PMRT sessions via Zoom. * In vivo PMRT relaxing session and Guided Imagery conducted by the Psychotherapist (T1; day 7). * Follow-up phase (T2; day 14), after two weeks. Recovering the in-imagination relaxing scenario and PMRT session.

Progressive Muscle Relaxation training via Zoom and Guided Imagery exposure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • General population
  • Italian speaker
  • Adult (age=\> 18)
  • Must be able to use a PC
  • Must be able to use a Smartphone

You may not qualify if:

  • Mental disorder diagnosis
  • Clinical diagnosis of a neurological disorder
  • Clinical diagnosis of epilepsy
  • Have cardiac pacemakers
  • Have metallic devices in the head-neck area
  • Clinical diagnosis of infectious disorders
  • Clinical diagnosis of gastrointestinal disorders
  • Open wounds at the face level
  • Clinical diagnosis of motor or visual dysfunctions
  • Neuromuscular pain prevent the use of Oculus Quest 2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Padova

Padua, 35131, Italy

Location

Related Publications (2)

  • Pardini S, Gabrielli S, Olivetto S, Fusina F, Dianti M, Forti S, Lancini C, Novara C. Personalized Virtual Reality Compared With Guided Imagery for Enhancing the Impact of Progressive Muscle Relaxation Training: Pilot Randomized Controlled Trial. JMIR Ment Health. 2024 Jan 30;11:e48649. doi: 10.2196/48649.

  • Pardini S, Gabrielli S, Olivetto S, Fusina F, Dianti M, Forti S, Lancini C, Novara C. Personalized, Naturalistic Virtual Reality Scenarios Coupled With Web-Based Progressive Muscle Relaxation Training for the General Population: Protocol for a Proof-of-Principle Randomized Controlled Trial. JMIR Res Protoc. 2023 Apr 17;12:e44183. doi: 10.2196/44183.

MeSH Terms

Conditions

Anxiety DisordersDepressionStress, Psychological

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Caterina Novara, PhD

    University of Padova

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 16, 2022

First Posted

July 28, 2022

Study Start

February 8, 2022

Primary Completion

July 24, 2023

Study Completion

July 24, 2023

Last Updated

November 29, 2023

Record last verified: 2023-11

Locations